DelveInsight launched a new report on Hunter Syndrome Market Insights, Epidemiology, and Market Forecast 2030.
DelveInsight’s ‘Hunter Syndrome Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understanding of the Hunter Syndrome, historical and forecasted epidemiology as well as the Hunter Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hunter syndrome is also known as Mucopolysaccharidosis type II (MPS II). It is a condition that affects many different parts of the body and mainly affects males. It is a progressive disorder, but the rate of progression varies among affected individuals. It is a rare, X-linked disorder caused due to a deficiency of the lysosomal enzyme iduronate-2-sulfatase, which plays a major role in the catabolism of glycosaminoglycans (GAG). In patients with mucopolysaccharidosis II, glycosaminoglycans accumulate within tissues and organs, contributing to the signs and symptoms of the disease.
Hunter Syndrome Epidemiology Insights:
1. The total Hunter Syndrome diagnosed prevalent population in the 7 major markets was found to be 1,145 in 2017.
2. In the case of Hunter Syndrome patients in the United States, the diagnosed prevalent cases were found to be 503 in 2017.
3. In the EU5 countries the diagnosed prevalence of Hunter Syndrome was found to be maximum in Germany with 83 cases, followed by the United Kingdom with 68 cases in 2017. While, the least number of cases were found in Spain, in 2017. The trend is expected to increase during the forecast period.
Hunter Syndrome Key Pharma Players Involved:
1. JCR Pharmaceuticals
2. Takeda
3. Denali Therapeutics
Hunter Syndrome Emerging Therapies Involved:
1. JR-141
2. TAK-609
3. DNL310
Request for a detailed sample copy of the report: https://www.delveinsight.com/sample-request/hunter-syndrome-market
“The market size of Hunter Syndrome in the seven major markets is USD 376.62 Million in 2017.”
Table of Contents:
1 Key Insight2 Executive Summary of Hunter Syndrome3 Hunter Syndrome Market Overview at a Glance4 Disease Background and Overview: Hunter Syndrome5 Case Reports6 Hunter Syndrome Epidemiology and Patient Population7 United States Epidemiology8 EU5 Epidemiology9 Japan Epidemiology10 Current Hunter Syndrome Treatment and Medical Practices11 Unmet needs12 Hunter Syndrome Marketed Drugs13 Hunter Syndrome Emerging Drugs14 Hunter Syndrome 7MM Market Analysis15 United States16 EU-5 countries: Market Outlook17 Japan Market Outlook18 Hunter Syndrome Market Drivers19 Hunter Syndrome Market Barriers20 SWOT Analysis21 Reimbursement and market access22 Appendix23 DelveInsight Capabilities24 Disclaimer25 About DelveInsight
Download our full report: https://www.delveinsight.com/report-store/hunter-syndrome-market
About DelveInsightDelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Shruti ThakurEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: www.delveinsight.com/